GSTP1 Ile105Val polymorphism confer susceptibility to oral cancer: a meta-analysis

Abstract

Abstract: PURPOSE: This meta-analysis was aimed to evaluate the association of glutathione S-transferase P1 (GSTP1) Ile105Val genetic polymorphism with susceptibility to oral cancer. METHODS: A literature search of PubMed, Chinese BioMedical, Wanfang, VIP, CNKI databases was conducted from inception to July 15th, 2013. Crude odd ration (OR) with 95% confidence intervals (CI) was calculated. RESULTS: Thirteen case-control studies were assessed, including 2,019 oral cancer patients and 3,282 healthy controls. Meta-analysis showed that the overall association between GSTP1 Ile105Val polymorphism and susceptibility to oral cancer was not significant. However, further stratified analyses based on ethnicity indicated that this association was significant in East Asians (Val vs. Ile: OR=1.42, 95%CI: 1.06-1.90, P=0.019; Val/Val+Ile/Val vs. Ile/Ile: OR=1.59, 95%CI: 1.13-2.23, P=0.007) and Euro Caucasians (Val vs. Ile: OR=1.34, 95%CI: 1.03-1.75, P=0.032; Val/Val+Ile/Val vs. Ile/Ile: OR=1.66, 95%CI: 1.15-2.38, P=0.006), but not significant in South Asians and America Caucasians. CONCLUSIONS: This meta-analysis provides further evidence that GSTP1 Ile105Val polymorphism may be associated with oral cancer risk among East Asians and Euro Caucasians. However, further large-scale studies are needed to determine the association of GSTP1 Ile105Val genetic polymorphism with susceptibility to oral cancer.

Key words: GSTP1, Polymorphism, Oral cancer, Meta analysis

CLC Number:

R739.8

YAN Jin, XIE Li-ming, SHEN Guo-fang, YU De-dong, WANG Yi-lin. GSTP1 Ile105Val polymorphism confer susceptibility to oral cancer: a meta-analysis[J]. Shanghai Journal of Stomatology, 2014, 23(4): 498-504.

References

[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[2] Mayne ST, Cartmel B, Kirsh V, et al. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx [J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(12): 3368-3374.
[3] Petersen PE. Oral cancer prevention and control-the approach of the World Health Organization [J]. Oral Oncol, 2009, 45(4-5): 454-460.
[4] Tanaka T, Tanaka M. Oral carcinogenesis and oral cancer chemoprevention: a review [J]. Patholog Res Int, 2011, 2011: 431246.
[5] Shiu MN, Chen TH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer [J]. Eur J Cancer Prev, 2004, 13(1): 39-45.
[6] Shaw R. The epigenetics of oral cancer [J]. Int J Oral Maxillofac Surg, 2006, 35(2): 101-108.
[7] Ruwali M, Singh M, Pant MC, et al. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer [J]. Xenobiotica, 2011, 41(12): 1122-1130.
[8] Karen-Ng LP, Marhazlinda J, Rahman ZA, et al. Combined effects of isothiocyanate intake, glutathione S-transferase polymorphisms and risk habits for age of oral squamous cell carcinoma development[J]. Asian Pac J Cancer Prev, 2011, 12(5): 1161-1166.
[9] Chen MK, Tsai HT, Chung TT, et al. Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer [J]. Head Neck, 2010, 32(8): 1079-1087.
[10] Duarte EC, Ribeiro DC, Gomez MV, et al. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression [J]. Anticancer Res, 2008, 28(2A): 1101-1106.
[11] Sikdar N, Paul RR and Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers [J]. Int J Cancer, 2004, 109(1): 95-101.
[12] Park JY, Schantz SP, Stern JC, et al. Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk [J]. Pharmacogenetics, 1999, 9(4): 497-504.
[13] Katoh T, Kaneko S, Takasawa S, et al. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer [J]. Pharmacogenetics, 1999, 9(2): 165-169.
[14] Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers [J]. Int J Cancer, 1999, 81(1): 44-48.
[15] Matthias C, Bockmühl U, Jahnke V, et al. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas [J]. Pharmacogenetics, 1998, 8(1): 1-6.
[16] Yadav DS, Devi TR, Ihsan R, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population [J]. Genet Test Mol Biomarkers, 2010, 14(5): 715-723.
[17] Mahimkar MB, Samant TA, Kannan S, et al. Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients[J]. Oral Oncol,2010,46(10):761-766.
[18] Hatagima A, Costa EC, Marques CF, et al. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil [J]. Oral Oncol, 2008, 44(2): 200-207.
[19] Peters ES, McClean MD, Marsit CJ, et al. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2196-2202.
[20] Amador AG, Righi PD, Radpour S, et al. Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002, 93(4): 440-445.
[21] da Costa BR, Cevallos M, Altman DG, et al. Uses and misuses of the STROBE statement: bibliographic study [J]. BMJ Open, 2011, 1(1): e000048.
[22] Jackson D, Baker R, Bowden J. A sensitivity analysis framework for the treatment effect measure used in the meta-analysis of comparative binary data from randomised controlled trials [J]. Stat Med, 2013, 32(6): 931-940.
[23] Peters JL, Sutton AJ, Jones DR, et al. Comparison of two methods to detect publication bias in meta-analysis[J]. JAMA,2006,295(6): 676-680.
[24] Zintzaras E, Chatzoulis DZ, Karabatsas CH, et al. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis [J]. J Hum Genet, 2005, 50(6): 267-275.
[25] Lee SA, Fowke JH, Lu W, et al. Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk [J]. Am J Clin Nutr, 2008, 87(3): 753-760.
[26] Rybicki BA, Neslund-Dudas C, Nock NL, et al. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism [J]. Cancer Detect Prev, 2006, 30(5): 412-422.
[27] Sun N, Sun X, Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer [J]. Cancer Chemother Pharmacol, 2010, 65(3): 437-446.